Browsing by Author Friedlander, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2016Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learnedKing, Madeleine; Mercieca-Bebber, Rebecca; Friedlander, M; Psychology; PsychologyPatient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned, Annals of Oncology, vol.27, Supp 1, 2016,pp i66-i71
2017Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyBuizen, L; King, Madeleine; O'Connell, Rachel; Roncolato, Felicia; Stockler, Martin; Aotani, Enriko; Avall-Lundqvist, Elisabeth; Berek, Jonathan; Berton-Rigaud, Dominique; Donnellan, Paul; Feeney, Amanda; Friedlander, M; Heitz, Florian; Hilpert, Felix; Joly, F; Lanceley, Anne; Okamoto, Aikou; Oza, Amit; Pignata, Sandro; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreReducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study, The Oncologist, vol.22, 9, 2017,pp 1117-1124